Latest: FDA Approves New Biosimilar for Oncology Treatment

STAT+: Former FDA head Stephen Hahn joins radiopharmaceuticals startup as CEO

0 Mins
Former FDA commissioner Stephen Hahn is taking the top spot at radiopharmaceuticals startup.
Tags:
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago